ES2127762T3 - Quinoleinas 2-sustituidas para el tratamiento de las leismaniosis. - Google Patents

Quinoleinas 2-sustituidas para el tratamiento de las leismaniosis.

Info

Publication number
ES2127762T3
ES2127762T3 ES92921565T ES92921565T ES2127762T3 ES 2127762 T3 ES2127762 T3 ES 2127762T3 ES 92921565 T ES92921565 T ES 92921565T ES 92921565 T ES92921565 T ES 92921565T ES 2127762 T3 ES2127762 T3 ES 2127762T3
Authority
ES
Spain
Prior art keywords
group
alkyl
alkenyl
phenyl
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921565T
Other languages
English (en)
Inventor
Alain Fournet
Barrios Alcira Angelo
Victoria Munoz
Reynald Hocquemiller
Francois Roblot
Jean Bruneton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Francais de Recherche Scientifique pour Developpement en Cooperation ORSTOM
Original Assignee
Institut Francais de Recherche Scientifique pour Developpement en Cooperation ORSTOM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Francais de Recherche Scientifique pour Developpement en Cooperation ORSTOM filed Critical Institut Francais de Recherche Scientifique pour Developpement en Cooperation ORSTOM
Application granted granted Critical
Publication of ES2127762T3 publication Critical patent/ES2127762T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION TIENE POR OBJETO QUINOLINAS SUSTITUIDAS, DE FORMULA GENERAL (I), EN LA QUE R1, R3, R4, R5, R6 Y R7 REPRESENTAN CADA SEPARADAMENTE UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO, ALQUENILO, EPOXIALQUILO O GRUPO MONO O POLIALCOHOL EN C1 A C7 LINEAL O RAMIFICADO, UN GRUPO AMINO O UN GRUPO AMIDA, UN GRUPO OR, EN EL QUE R REPRESENTA EL HIDROGENO O UN GRUPO ALQUILO O ALQUENILO EN C1-7, O UN GRUPO FENILO; Y R2 REPRESENTA: UN GRUPO OR, EN EL QUE R TIENE LA MISMA SIGNIFICACION QUE ANTERIORMENTE, O BIEN, UN GRUPO ALQUILO, ALQUENILO, O EPOXIALQUILO EN C1 A C7, UN GRUPO FENILO, UN GRUPO FENOL, METILENEDIOXIFENILO, DIMETOXIFENILO, O BIEN UN GRUPO ALQUILO, ALQUENILO O EPOXIALQUILO EN C1-7, LLEVANDO AL MENOS UNO DE LOS SIGUIENTES SUSTITUYENTES: UN GRUPO ALQUILO O ALQUENILO EN C1-4; UN GRUPO FENILO, FENOL, DIMETILFENILO, DIMETOXIFENILO, METILENEDIOXIFENILO; O UN GRUPO OR'', EN EL QUE R'' REPRESENTA EL HIDROGENO O UN GRUPO ALQUILO, O ALQUENILO EN C1-4; O UN GRUPO NHR", EN EL QUE R" REPESENTA HIDROGENO OUN GRUPO ALQUILO O ALQUENILO EN C1-4; O UN GRUPO AMIDA, O BIEN -R2 Y R3 FORMAN JUNTAMENTE UN CICLO FURANO; ASI COMO SUS SALES Y SUS DERIVADOS, PARA LA UTILIZACION COMO MEDICAMENTOS, ESPECIALMENTE COMO ANTILEISHMANIENICOS.
ES92921565T 1991-10-03 1992-09-29 Quinoleinas 2-sustituidas para el tratamiento de las leismaniosis. Expired - Lifetime ES2127762T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112174A FR2682107B1 (fr) 1991-10-03 1991-10-03 Quinoleines 2-substituees pour le traitement des leishmanioses.

Publications (1)

Publication Number Publication Date
ES2127762T3 true ES2127762T3 (es) 1999-05-01

Family

ID=9417546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921565T Expired - Lifetime ES2127762T3 (es) 1991-10-03 1992-09-29 Quinoleinas 2-sustituidas para el tratamiento de las leismaniosis.

Country Status (10)

Country Link
US (1) US5541196A (es)
EP (1) EP0606380B1 (es)
JP (1) JP3728627B2 (es)
AT (1) ATE173727T1 (es)
DE (1) DE69227695D1 (es)
ES (1) ES2127762T3 (es)
FR (1) FR2682107B1 (es)
GR (1) GR3029471T3 (es)
OA (1) OA09930A (es)
WO (1) WO1993007125A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819507B1 (fr) * 2001-01-17 2007-09-28 Inst Rech Developpement Ird Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
US9321730B2 (en) * 2007-08-21 2016-04-26 The Hong Kong Polytechnic University Method of making and administering quinoline derivatives as anti-cancer agents
FR2929943B1 (fr) 2008-04-15 2010-09-24 Inst Rech Developpement Ird Sels de quinoleines 2-substituees
FR2931479B1 (fr) * 2008-05-20 2012-12-07 I R D Nouveaux derives de quinoleines 2-substituees et un procede pour leur preparation
WO2012083866A1 (en) 2010-12-22 2012-06-28 The Hong Kong Polytechnic University Quinoline derivatives as anti-cancer agents
MX2016004464A (es) * 2013-10-10 2017-01-12 Univ Leuven Kath Derivados novedosos de pradimicina para el tratamiento de enfermedades provocadas por kinetoplastidos.
ES2818531T3 (es) 2015-12-17 2021-04-13 Biokine Therapeutics Ltd Moléculas pequeñas para inhibir la actividad de las quimiocinas y/o el crecimiento de células cancerosas
WO2020206252A1 (en) * 2019-04-03 2020-10-08 University Of Central Florida Research Foundation, Inc. Antimalarial compounds
CN114096524B (zh) 2019-05-15 2025-03-04 阿龙拜欧有限公司 用于治疗癌症、抑制趋化因子活性和/或诱导细胞死亡的小分子
CN110229101B (zh) * 2019-05-31 2020-11-03 浙江工业大学 用于检测黏度的aie荧光化合物及其制备与应用
WO2021150645A1 (en) * 2020-01-20 2021-07-29 Crescenta Biosciences Novel cell metabolism modulating compounds and uses thereof
EP4171736A4 (en) 2020-06-27 2024-07-03 Crescenta Biosciences NEW CELL METABOLISM MODULATING COMPOUNDS AND THEIR USES
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds
WO2025091990A1 (zh) * 2023-10-30 2025-05-08 湖北工程学院 一种壳聚糖铜MOF材料及其应用、β-硼亚胺化合物和羟基化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636216A (en) * 1968-09-26 1972-01-18 Salsbury Lab Coccidiosis control with quinalinol derivatives
US4209519A (en) * 1978-03-13 1980-06-24 The United States Of America As Represented By The Secretary Of The Army Anti-leishmanial lepidine derivatives
IL89026A (en) * 1988-01-29 1993-02-21 Lilly Co Eli Substituted quinolines and cinnolines, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them

Also Published As

Publication number Publication date
GR3029471T3 (en) 1999-05-28
FR2682107A1 (fr) 1993-04-09
OA09930A (fr) 1994-11-15
FR2682107B1 (fr) 1995-04-21
JPH07501048A (ja) 1995-02-02
DE69227695D1 (de) 1999-01-07
EP0606380B1 (fr) 1998-11-25
US5541196A (en) 1996-07-30
JP3728627B2 (ja) 2005-12-21
ATE173727T1 (de) 1998-12-15
WO1993007125A1 (fr) 1993-04-15
EP0606380A1 (fr) 1994-07-20

Similar Documents

Publication Publication Date Title
GR3029471T3 (en) 2-substituted quinolines for treating leishmanioses.
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PL290676A1 (en) Method of obtaining novel derivatives of 2-aminoalkyl-5-diaryl-alkyl-1.3-dioxane
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
EP0683788A1 (en) 3'-AZIRIDINO-ANTHRACYCLINE DERIVATIVES.
SU1568887A3 (ru) Cпocoб пoлучehия пипepaзиhcoдepжaщиx углeboдopoдob или иx kиcлotho-aддиtиbhыx coлeй
DE69624459D1 (de) Kondensierte indan-derivate und ihre salze
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
DK0395527T3 (da) Imidazobenzodiazepiner og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf
ATE136029T1 (de) Carbostyrylderivate
ES2120039T3 (es) Nuevos acildipeptidos heterociclicos, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
HUP0101046A2 (hu) Amiloidózis kezelésére alkalmazható amino-antraciklinon-származékok és ezeket tartalmazó gyógyszerkészítmények
DE69917236D1 (de) Heterocyclische anthracyclinonderivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 606380

Country of ref document: ES